Search results
Found 6 matches for
The collective force of cancer research, outreach and care across the city of Oxford, translating discoveries into better care for cancer patients.
SCALOP team discover new pancreatic cancer biomarker
- Biomarkers
- Clinical Trial
- Diagnosis & Risk
- Early Detection
- Pancreatic Cancer
- Pancreatic Cancer Awareness Month
- Treatment
27 November 2020
The SCALOP clinical trial team have uncovered a new therapeutic target for locally advanced pancreatic cancer. Read more about it and the next steps for the SCALOP-2 trial.
The search for pancreatic cancer biomarkers
- Biomarkers
- Cancer Big Data
- Diagnosis & Risk
- Early Detection
- Pancreatic Cancer
- Pancreatic Cancer Awareness Month
23 November 2020
Nuffield Department of Population Health researchers are using the China Kadoorie Biobank to identify potential protein biomarkers in the blood that could be used to predict the presence or development of pancreatic cancer
What we can learn from cancer survivors
- Checkpoint Therapy
- Collaboration
- Drug Discovery
- Immunology
- Immunotherapy
- Pancreatic Cancer
- Pancreatic Cancer Awareness Month
- Treatment
19 November 2020
Understanding how an individual survives cancer, and why they respond well to therapy, can be vital in identifying new therapeutic targets. A new project seeks to see why some advanced pancreatic cancer patients overcome the odds and respond positively to treatment.
Early stage ‘red flag’ symptoms for pancreatic cancer
- Cancer Big Data
- Early Detection
- Pancreatic Cancer
- Pancreatic Cancer Awareness Month
- Population Health
17 November 2020
The ADEPTS study uses the QResearch database to better understand what ‘red flag’ symptoms may be associated with pancreatic cancer, in the hopes of promoting earlier diagnosis from primary care.
Detecting pancreatic cancer through blood tests
- Biomarkers
- Diagnosis & Risk
- Early Detection
- Genetics
- New Technology
- Pancreatic Cancer
- Pancreatic Cancer Awareness Month
9 November 2020
The Song Lab recently developed an effective and accurate way of detecting cancer biomarkers in the blood. Now, they are looking at the application of TAPS technology in pancreatic cancer
Innovative drug delivery techniques show promise in clinical trials
- Clinical Trial
- Drug Delivery
- New Technology
- Pancreatic Cancer
- Pancreatic Cancer Awareness Month
- Precision Medicine
- Treatment
2 November 2020
Dr Laura Spiers talks about the TarDox and PanDox trials, which are using novel drug delivery techniques to improve the uptake of chemotherapy drugs into pancreatic tumours and other cancers